• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鞘氨醇-1-磷酸受体-3 信号上调表皮生长因子受体并增强培养的肺腺癌细胞中表皮生长因子受体介导的致癌活性。

Sphingosine-1-phosphate receptor-3 signaling up-regulates epidermal growth factor receptor and enhances epidermal growth factor receptor-mediated carcinogenic activities in cultured lung adenocarcinoma cells.

机构信息

Bioactive Lipid Research Program, Department of Pathology, Wayne State University School of Medicine, 423 Chemistry Building, Detroit, MI 48202, USA.

出版信息

Int J Oncol. 2012 May;40(5):1619-26. doi: 10.3892/ijo.2012.1379. Epub 2012 Feb 16.

DOI:10.3892/ijo.2012.1379
PMID:22344462
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3797598/
Abstract

Sphingosine-1-phosphate (S1P) regulates a wide array of biological functions. However, the role of S1P signaling in tumorigenesis remains to be elucidated. In this study, we show that S1P receptor subtype 3 (S1P₃) is markedly up-regulated in a subset of lung adenocarcinoma cells compared to normal lung epithelial cells. Specific knockdown of S1P₃ receptors inhibits proliferation and anchorage-independent growth of lung adenocarcinoma cells. Mechanistically, we demonstrate that S1P₃ signaling increases epidermal growth factor receptor (EGFR) expression via the Rho kinase (ROCK) pathway in lung adenocarcinoma cells. Nuclear run-off analysis indicates that S1P/S1P₃ signaling transcriptionally increases EGFR expression. Knockdown of S1P₃ receptors diminishes the S1P-stimulated EGFR expression in lung adenocarcinoma cells. Moreover, S1P treatment greatly enhances EGF-stimulated colony formation, proliferation and invasion of lung adenocarcinoma cells. Together, these results suggest that the enhanced S1P₃-EGFR signaling axis may contribute to the tumorigenesis or progression of lung adenocarcinomas.

摘要

鞘氨醇-1-磷酸(S1P)调节广泛的生物学功能。然而,S1P 信号在肿瘤发生中的作用仍有待阐明。在这项研究中,我们表明 S1P 受体亚型 3(S1P₃)在与正常肺上皮细胞相比的肺腺癌细胞亚群中显著上调。S1P₃ 受体的特异性敲低抑制肺腺癌细胞的增殖和非锚定依赖性生长。在机制上,我们证明 S1P₃ 信号通过肺腺癌细胞中的 Rho 激酶(ROCK)通路增加表皮生长因子受体(EGFR)的表达。核流出分析表明,S1P/S1P₃ 信号通过转录增加 EGFR 的表达。S1P₃ 受体的敲低可减少 S1P 刺激的肺腺癌细胞中 EGFR 的表达。此外,S1P 处理大大增强了 EGF 刺激的肺腺癌细胞集落形成、增殖和侵袭。总之,这些结果表明增强的 S1P₃-EGFR 信号轴可能有助于肺腺癌的肿瘤发生或进展。

相似文献

1
Sphingosine-1-phosphate receptor-3 signaling up-regulates epidermal growth factor receptor and enhances epidermal growth factor receptor-mediated carcinogenic activities in cultured lung adenocarcinoma cells.鞘氨醇-1-磷酸受体-3 信号上调表皮生长因子受体并增强培养的肺腺癌细胞中表皮生长因子受体介导的致癌活性。
Int J Oncol. 2012 May;40(5):1619-26. doi: 10.3892/ijo.2012.1379. Epub 2012 Feb 16.
2
Cross-talk between LPA1 and epidermal growth factor receptors mediates up-regulation of sphingosine kinase 1 to promote gastric cancer cell motility and invasion.溶血磷脂酸受体1(LPA1)与表皮生长因子受体之间的相互作用介导了鞘氨醇激酶1的上调,从而促进胃癌细胞的运动和侵袭。
Cancer Res. 2008 Aug 15;68(16):6569-77. doi: 10.1158/0008-5472.CAN-08-0411.
3
ETS-1-mediated transcriptional up-regulation of CD44 is required for sphingosine-1-phosphate receptor subtype 3-stimulated chemotaxis.ETS-1 介导的转录上调 CD44 是鞘氨醇 1-磷酸受体亚型 3 刺激趋化所必需的。
J Biol Chem. 2013 Nov 8;288(45):32126-32137. doi: 10.1074/jbc.M113.495218. Epub 2013 Sep 24.
4
TGF-β/SMAD3 Pathway Stimulates Sphingosine-1 Phosphate Receptor 3 Expression: IMPLICATION OF SPHINGOSINE-1 PHOSPHATE RECEPTOR 3 IN LUNG ADENOCARCINOMA PROGRESSION.转化生长因子-β/信号转导分子 Mothers against decapentaplegic 3(TGF-β/SMAD3)信号通路刺激1-磷酸鞘氨醇受体3表达:1-磷酸鞘氨醇受体3在肺腺癌进展中的意义
J Biol Chem. 2016 Dec 30;291(53):27343-27353. doi: 10.1074/jbc.M116.740084. Epub 2016 Nov 17.
5
Sphingosine-1-phosphate receptor-2 mediated NFκB activation contributes to tumor necrosis factor-α induced VCAM-1 and ICAM-1 expression in endothelial cells.鞘氨醇-1-磷酸受体-2 介导的 NFκB 激活有助于肿瘤坏死因子-α诱导内皮细胞中 VCAM-1 和 ICAM-1 的表达。
Prostaglandins Other Lipid Mediat. 2013 Oct;106:62-71. doi: 10.1016/j.prostaglandins.2013.06.001. Epub 2013 Jun 11.
6
Sphingosine 1-phosphate receptor 2 signals through leukemia-associated RhoGEF (LARG), to promote smooth muscle cell differentiation.鞘氨醇 1-磷酸受体 2 通过白血病相关 RhoGEF(LARG)发出信号,促进平滑肌细胞分化。
Arterioscler Thromb Vasc Biol. 2010 Sep;30(9):1779-86. doi: 10.1161/ATVBAHA.110.209395. Epub 2010 Aug 11.
7
Extracellular Sphingosine-1-Phosphate Downstream of EGFR Increases Human Glioblastoma Cell Survival.表皮生长因子受体下游的细胞外鞘氨醇-1-磷酸增加人胶质母细胞瘤细胞的存活率。
Int J Mol Sci. 2021 Jun 25;22(13):6824. doi: 10.3390/ijms22136824.
8
Exogenous S1P via S1P receptor 2 induces CTGF expression through Src-RhoA-ROCK-YAP pathway in hepatic stellate cells.外源性 S1P 通过 S1P 受体 2 通过Src-RhoA-ROCK-YAP 通路诱导肝星状细胞中 CTGF 的表达。
Mol Biol Rep. 2024 Sep 2;51(1):950. doi: 10.1007/s11033-024-09868-w.
9
Epidermal growth factor-induced cellular invasion requires sphingosine-1-phosphate/sphingosine-1-phosphate 2 receptor-mediated ezrin activation.表皮生长因子诱导的细胞侵袭需要鞘氨醇-1-磷酸/鞘氨醇-1-磷酸 2 受体介导的 ezrin 激活。
FASEB J. 2013 Aug;27(8):3155-66. doi: 10.1096/fj.13-228460. Epub 2013 Apr 29.
10
Low-density lipoprotein induced expression of connective tissue growth factor via transactivation of sphingosine 1-phosphate receptors in mesangial cells.低密度脂蛋白通过激活系膜细胞中鞘氨醇-1-磷酸受体的反式激活作用诱导结缔组织生长因子的表达。
Mol Endocrinol. 2012 May;26(5):833-45. doi: 10.1210/me.2011-1261. Epub 2012 Mar 15.

引用本文的文献

1
Sphingolipid metabolism dysregulation: A cause for lung cancer development, progression, and resistance to therapies.鞘脂代谢失调:肺癌发生、发展及治疗耐药的一个原因。
Chin Med J Pulm Crit Care Med. 2025 Jun 13;3(2):88-96. doi: 10.1016/j.pccm.2025.05.002. eCollection 2025 Jun.
2
Sphingosine-1-Phosphate Metabolic Pathway in Cancer: Implications for Therapeutic Targets.癌症中的鞘氨醇-1-磷酸代谢途径:对治疗靶点的影响
Int J Mol Sci. 2025 Jan 26;26(3):1056. doi: 10.3390/ijms26031056.
3
The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib.抑制鞘氨醇激酶1/鞘氨醇-1-磷酸/鞘氨醇-1-磷酸受体3信号通路可降低表皮生长因子受体的激活,并增加非小细胞肺癌对吉非替尼的敏感性。
Curr Res Pharmacol Drug Discov. 2025 Jan 9;8:100212. doi: 10.1016/j.crphar.2024.100212. eCollection 2025.
4
Development of a Custom Fluid Flow Chamber for Investigating the Effects of Shear Stress on Periodontal Ligament Cells.定制流体流室的开发用于研究切应力对牙周韧带细胞的影响。
Cells. 2024 Oct 23;13(21):1751. doi: 10.3390/cells13211751.
5
Targeting sphingosine 1-phosphate receptor 3 inhibits T-cell exhaustion and regulates recruitment of proinflammatory macrophages to improve antitumor efficacy of CAR-T cells against solid tumor.靶向鞘氨醇 1-磷酸受体 3 抑制 T 细胞耗竭并调节促炎巨噬细胞的募集,以提高 CAR-T 细胞对实体瘤的抗肿瘤疗效。
J Immunother Cancer. 2023 Aug;11(8). doi: 10.1136/jitc-2022-006343.
6
Sphingosine-1-Phosphate-Triggered Expression of Cathelicidin LL-37 Promotes the Growth of Human Bladder Cancer Cells.鞘氨醇-1-磷酸触发的抗菌肽 LL-37 表达促进人膀胱癌的生长。
Int J Mol Sci. 2022 Jul 4;23(13):7443. doi: 10.3390/ijms23137443.
7
Sphingolipid Metabolism and Signaling in Lung Cancer: A Potential Therapeutic Target.肺癌中的鞘脂代谢与信号传导:一个潜在的治疗靶点
J Oncol. 2022 Jun 28;2022:9099612. doi: 10.1155/2022/9099612. eCollection 2022.
8
Extracellular Sphingosine-1-Phosphate Downstream of EGFR Increases Human Glioblastoma Cell Survival.表皮生长因子受体下游的细胞外鞘氨醇-1-磷酸增加人胶质母细胞瘤细胞的存活率。
Int J Mol Sci. 2021 Jun 25;22(13):6824. doi: 10.3390/ijms22136824.
9
Safety of S1P Modulators in Patients with Immune-Mediated Diseases: A Systematic Review and Meta-Analysis.S1P调节剂在免疫介导疾病患者中的安全性:一项系统评价和荟萃分析。
Drug Saf. 2021 Jun;44(6):645-660. doi: 10.1007/s40264-021-01057-z. Epub 2021 Mar 5.
10
Sphingosine-1-Phosphate: Its Pharmacological Regulation and the Treatment of Multiple Sclerosis: A Review Article.鞘氨醇-1-磷酸:其药理调节作用与多发性硬化症的治疗:一篇综述文章。
Biomedicines. 2020 Jul 18;8(7):227. doi: 10.3390/biomedicines8070227.

本文引用的文献

1
Sphingosine kinase 1/S1P pathway involvement in the GDNF-induced GAP43 transcription.丝氨酸磷酸激酶 1/鞘氨醇 1-磷酸途径参与 GDNF 诱导的 GAP43 转录。
J Cell Biochem. 2011 Nov;112(11):3449-58. doi: 10.1002/jcb.23275.
2
A role of sphingosine kinase 1 in head and neck carcinogenesis.丝氨酸激酶 1 在头颈部肿瘤发生中的作用。
Cancer Prev Res (Phila). 2011 Mar;4(3):454-62. doi: 10.1158/1940-6207.CAPR-10-0299. Epub 2011 Jan 5.
3
STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors.STAT3 诱导的 S1PR1 表达对于肿瘤中持续的 STAT3 激活至关重要。
Nat Med. 2010 Dec;16(12):1421-8. doi: 10.1038/nm.2250. Epub 2010 Nov 21.
4
FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1.FTY720(fingolimod)通过抑制鞘氨醇激酶-1 使前列腺癌细胞对放射治疗敏感。
Cancer Res. 2010 Nov 1;70(21):8651-61. doi: 10.1158/0008-5472.CAN-10-1388. Epub 2010 Oct 19.
5
T-lymphoblastic lymphoma cells express high levels of BCL2, S1P1, and ICAM1, leading to a blockade of tumor cell intravasation.T 淋巴母细胞淋巴瘤细胞表达高水平的 BCL2、S1P1 和 ICAM1,导致肿瘤细胞浸润受阻。
Cancer Cell. 2010 Oct 19;18(4):353-66. doi: 10.1016/j.ccr.2010.09.009.
6
High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patients.高表达的鞘氨醇 1-磷酸受体、S1P1 和 S1P3、鞘氨醇激酶 1 和细胞外信号调节激酶 1/2 与雌激素受体阳性乳腺癌患者对他莫昔芬耐药的发展相关。
Am J Pathol. 2010 Nov;177(5):2205-15. doi: 10.2353/ajpath.2010.100220. Epub 2010 Oct 1.
7
Overexpression of sphingosine kinase 1 is associated with salivary gland carcinoma progression and might be a novel predictive marker for adjuvant therapy.丝氨酸激酶 1 的过表达与唾液腺癌的进展相关,并且可能成为辅助治疗的新的预测标志物。
BMC Cancer. 2010 Sep 16;10:495. doi: 10.1186/1471-2407-10-495.
8
Sphingosine 1-phosphate and cancer.鞘氨醇 1-磷酸与癌症。
Nat Rev Cancer. 2010 Jul;10(7):489-503. doi: 10.1038/nrc2875. Epub 2010 Jun 17.
9
Expression of sphingosine-1-phosphate receptors and lysophosphatidic acid receptors on cultured and xenografted human colon, breast, melanoma, and lung tumor cells.鞘氨醇-1-磷酸受体和溶血磷脂酸受体在培养的及异种移植的人结肠、乳腺、黑素瘤和肺肿瘤细胞上的表达
Tumour Biol. 2010 Aug;31(4):341-9. doi: 10.1007/s13277-010-0043-7. Epub 2010 May 18.
10
Sphingosine kinase mediates resistance to the synthetic retinoid N-(4-hydroxyphenyl)retinamide in human ovarian cancer cells.鞘氨醇激酶介导人卵巢癌细胞对合成类视黄醇N-(4-羟基苯基)视黄酰胺的抗性。
J Biol Chem. 2010 Jun 11;285(24):18594-602. doi: 10.1074/jbc.M109.072801. Epub 2010 Apr 19.